Patient characteristics
| Variable . | n . | % . |
|---|---|---|
| Age, median (range), y | 55 (23-69) | — |
| Sex | ||
| M | 9 | 56 |
| F | 7 | 44 |
| Conditioning intensity | ||
| Myeloablative | 12 | 75 |
| Reduced | 4 | 25 |
| Disease | ||
| AML | 12 | 75 |
| MDS | 4 | 25 |
| Donor | ||
| Matched related | 6 | 37 |
| Matched unrelated | 7 | 44 |
| Mismatched related (haploidentical) | 3 | 19 |
| Status at HCT | ||
| CR1 | 7 | 44 |
| CR2 | 2 | 12 |
| Not in remission | 7 | 44 |
| Cytogenetic risk | ||
| Monosomal (+) | 9 | 56 |
| Monosomal (−) | 7 | 44 |
| Molecular | ||
| TP53 (+) | 6 | 37 |
| TP53 (−) | 7 | 44 |
| TP53 (n/a) | 3 | 19 |
| BM blast % at relapse (AML + MDS), median (range) | 21.5 (5-92) | - |
| BM blast % at relapse (AML), median (range) | 26.5 (5-92) | - |
| Prior GVHD before Pembrolizumab | ||
| No | 10 | 63 |
| Yes | 6 | 37 |
| On immune suppression at pembrolizumab start | ||
| No | 11 | 69 |
| Yes | 5 | 31 |
| Time of relapse post-HCT (range), d | 168.5 (66-1064) | - |
| Variable . | n . | % . |
|---|---|---|
| Age, median (range), y | 55 (23-69) | — |
| Sex | ||
| M | 9 | 56 |
| F | 7 | 44 |
| Conditioning intensity | ||
| Myeloablative | 12 | 75 |
| Reduced | 4 | 25 |
| Disease | ||
| AML | 12 | 75 |
| MDS | 4 | 25 |
| Donor | ||
| Matched related | 6 | 37 |
| Matched unrelated | 7 | 44 |
| Mismatched related (haploidentical) | 3 | 19 |
| Status at HCT | ||
| CR1 | 7 | 44 |
| CR2 | 2 | 12 |
| Not in remission | 7 | 44 |
| Cytogenetic risk | ||
| Monosomal (+) | 9 | 56 |
| Monosomal (−) | 7 | 44 |
| Molecular | ||
| TP53 (+) | 6 | 37 |
| TP53 (−) | 7 | 44 |
| TP53 (n/a) | 3 | 19 |
| BM blast % at relapse (AML + MDS), median (range) | 21.5 (5-92) | - |
| BM blast % at relapse (AML), median (range) | 26.5 (5-92) | - |
| Prior GVHD before Pembrolizumab | ||
| No | 10 | 63 |
| Yes | 6 | 37 |
| On immune suppression at pembrolizumab start | ||
| No | 11 | 69 |
| Yes | 5 | 31 |
| Time of relapse post-HCT (range), d | 168.5 (66-1064) | - |
CR1, first complete remission; CR2, second complete remission; F, female; M, male.